Red Queen Bio is using AI to design antibodies for future viruses, WSJ says

Red Queen Bio, a biosecurity startup backed by OpenAI, has raised $36 million in total to design antibody drugs against viruses, including ones that AI systems could one day help create, The Wall Street Journal reported. The company is starting with antibodies against bird flu and other influenza viruses and plans its first clinical trials […] This story continues at The Next Web

Read it at The Next Web ↗

← Front page